Advertisement

Barinthus Biotherapeutics PLC BRNS

Set alert

Price alert · BRNS

All alert types
0.74 USD -0.02 -2.49%

At close · Sep 8

0.74 0.00 -0.57%

After hours · Sep 8, 4:00 PM ET

Bid
0.65 × 3
Ask
0.76 × 5
0.6421 Day range 0.7629
0.801 52-week range 4.16
YTD
+5.73%
1 year
-19.82%
Open
0.7443
Prev close
0.759
Mkt cap
44.65M
Vol
376.14K
Avg vol
54.43K
EPS
-1.49
P/E
0.00
Div yield
0.00%
More statistics
Low
0.6421
High
0.7629
Forward P/E
-0.62
Beta
-0.58
Short ratio
0.19
Inst. own
46.22%
Dividend
0.00
Ex-div date
Earnings
Aug 8, 2024
50-d avg
1.16
200-d avg
1.66
1y target
7.25

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for BRNS has not been loaded yet. Try again in a moment.

Revenue & Expenses

Other Income → Expenses: $1.26MIncome Tax Benefit → Expenses: $3.00KExpenses → Selling, General & Admin: $13.42MExpenses → Research & Development: $10.53MExpenses → Other Operating Expenses: $398.00KGross Profit → Expenses: $14.97MRevenue → Gross Profit: $14.97MNet Loss → Expenses: $8.11MOther Income$1.26MIncome Tax Benefit$3.00KGross Profit$14.97MNet Loss$8.11MExpenses$24.35MSelling, General & Admin$13.42MResearch & Development$10.53MOther Operating Expenses$398.00KRevenue$14.97M

Period ending Jun 30, 2026 · select a line to chart its history

Income statement

BRNS quarterly income statement
11.02M
3.92M
7.10M
-11.02M
14.00K
-23.00K
-10.58M
-10.58M
-10.58M
-10.60M
-19.00K
-0.26
-0.26
-0.26
-10.59M
-10.59M
40.85M
40.85M

Balance sheet

BRNS quarterly balance sheet
59.63M
59.63M
63.27M
4.66M
81.89M
1.72M
10.29M
11.42M
8.57M
24.76M
-320.21M
-17.74M
57.07M
57.07M
18.62M
10.29M
335.00K
13.04M
13.34M
535.00K
1.28M
215.00K

Cash flow

BRNS quarterly cash flow
1.02M
-7.56M
61.00K
61.00K
-8.09M
471.00K
433.00K
Advertisement